We want to identify really useful peptides that can be leveraged and advanced as treatment for human diseases for which there is no solution at the moment. One potential prospect is MOTs-C, which Cohen discovered and has studied in Phase 1A and Phase 1B trials
Effects of diclofenac, L-NAME, L-arginine, and pentadecapeptide BPC 157 on gastrointestinal, liver, and brain lesions, failed anastomosis deterioration in 24 hour-short-bowel rats
Regulatory status Injectable GHK-Cu is not FDA-approved for any condition
You'll find this ingredient in the vast majority of skincare (for good reason)
The peptide accelerates tissue repair, reduces scarring, and supports follicle regeneration after injury
The effects of IV infusion therapy can be noticed relatively quickly